An open, phase IV study on the immunogenicity and tolerability of Influsplit SSW (Rm) 2005/2006 in children aged 6-13 years.
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 22 Oct 2006 New trial record.